Key immune-cell populations in the TME include tumour-associated macrophages (TAMs), CD4-expressing or ‘positive’ (CD4+) and CD8-positive (CD8+) T-cell subsets, B-cells, plasma cells, eosinophils, and mast cells [19,20]. This evidence concerns the gene CD4 and neoplasm.